RESUMEN
The inner blood-retinal barrier is a gliovascular unit in which glial cells surround capillary endothelial cells and regulate retinal capillaries by paracrine interactions. During chronic ocular inflammation, microvascular complications can give rise to vascular proliferative lesions, which compromise visual acuity. This pathologic remodelling caused by proliferating Müller cells determines occlusion of retinal capillaries. The aim of the present study was to identify qualitative and quantitative alterations in the retinal capillaries in patients with post-traumatic chronic ocular inflammation or post-thrombotic vascular glaucoma. Moreover, we investigated the potential role of vascular endothelial growth factor (VEGF) and pro-inflammatory cytokines in retinal inflammation. Our electron microscopy findings demonstrated that during chronic ocular inflammation, thickening of the basement membrane, loss of pericytes and endothelial cells and proliferation of Müller cells occur with irreversible occlusion of retinal capillaries. Angiogenesis takes place as part of a regenerative reaction that results in fibrosis. We believe that VEGF and pro-inflammatory cytokines may be potential therapeutic targets in the treatment of this disease although further studies are required to confirm these findings.
RESUMEN
We have retrospectively reviewed our use of the S-MART sterile silicon ring self-exsanguinating tourniquet in 300 consecutive minor hand surgical procedures. A total of 3 postoperative complications were identified, only 1 of which was directly related to the tourniquet's use. We outline the reasons of why we feel that this device provides a safe and effective bloodless field and the benefits of its use.
RESUMEN
Human pterygium is made up of chronic proliferative fibro-vascular tissue growing on the ocular surface. This disease exhibits both degenerative and hyperplastic properties. Some fibroangiogenic factors have recently been shown to play a potential role in fibrovascular diseases via the angiogenesis process. The aim of this study is to evaluate VEGF, TGF-ß and PGE2 expression in the epithelial, endothelial and stromal cells of human pterygium and normal conjunctiva in order to determine whether these factors participate in the development of pterygium. Ten specimens from patients with pterygium and two normal conjunctivas (cadavers) were analyzed by immunohistochemistry using specific antibodies against these growth factors. The technique used was ABC/HRP (Avidin complexed with biotinylated peroxidase). Immunoreactivity of VEGF was significantly increased in the epithelium, vascular endothelium and stromal cells in primary pterygium as compared with normal conjunctiva. A moderate expression of TGF-ß in the pterygium was observed in the epithelial and stromal layers. On the contrary, immunolabeling of this growth factor in the human normal conjunctiva was weak. PGE2 was strongly expressed in the epithelium of patients with pterygium, as in control conjunctival tissues, and the immunolabeling was moderate in the stroma from the same patients. Our results suggest that these growth factors may contribute to the progression of primary pterygium by increasing angiogenesis, thus leading to the formation of new blood vessels from the pre-existing vasculature. We conclude that VEGF, TGF-ß and PGE2 may be potential therapeutic targets in the treatment of this disease although proof of this evidence requires further studies.
Asunto(s)
Conjuntiva/química , Dinoprostona/análisis , Inmunohistoquímica , Pterigion/metabolismo , Factor de Crecimiento Transformador beta/análisis , Factor A de Crecimiento Endotelial Vascular/análisis , Anciano , Anciano de 80 o más Años , Biomarcadores/análisis , Estudios de Casos y Controles , Conjuntiva/patología , Células Endoteliales/química , Células Epiteliales/química , Femenino , Humanos , Hiperplasia , Masculino , Persona de Mediana Edad , Pterigion/patología , Células del Estroma/químicaRESUMEN
AIMS: To evaluate the ocular hypotensive effects and tolerability of the once daily fixed combination latanoprost-timolol versus twice daily 0.50% timolol associated or not with once daily latanoprost in patients suffering from Primary Open-Angle Glaucoma (POAG). METHODS: We compared the effects of such a combination with those of 0.50% timolol alone twice daily in a group of 24 patients and with the effects of timolol 0.50% twice daily associated with once daily latanoprost in a second group of 20 patients with a follow-up of 24 months. RESULTS: In the first group of patients after one month the Intraocular Pressure (IOP) was reduced from a mean of 19.93 to a 17.04 mmHg. This reduction remained stable with a mean value of 17.00 mmHg at the third month, of 16.49 mmHg at the sixth month, of 17.04 at the twelfth month, 16.00 at the eighteenth month, and of 15.86 mmHg in the twenty-fourth month. In the second group there was a statistically significant reduction from 19.4 to 16.84 mmHg after one month. This reduction remained constant with mean values of 16.47 at the sixth month, of 16.20 at the twelfth month and of 16.00 mmHg at the twentyfourth month of treatment. CONCLUSIONS: The once daily latanoprost-timolol combination was shown to furtherly reduce the Intraocular Pressure (IOP) (p=0.001) and to maintain under control the intraocular pressure for the observation period (24 months). Both topical and systemic side-effects were scarse and tolerability was good.
Asunto(s)
Antihipertensivos/uso terapéutico , Glaucoma de Ángulo Abierto/tratamiento farmacológico , Prostaglandinas F Sintéticas/uso terapéutico , Timolol/uso terapéutico , Administración Tópica , Antihipertensivos/administración & dosificación , Antihipertensivos/efectos adversos , Combinación de Medicamentos , Femenino , Estudios de Seguimiento , Glaucoma de Ángulo Abierto/fisiopatología , Humanos , Presión Intraocular/efectos de los fármacos , Latanoprost , Masculino , Prostaglandinas F Sintéticas/administración & dosificación , Prostaglandinas F Sintéticas/efectos adversos , Factores de Tiempo , Timolol/administración & dosificación , Timolol/efectos adversos , Resultado del TratamientoRESUMEN
Antidromic stimulation of the rat trigeminal ganglion triggers the release of substance P (SP) and calcitonin gene-related peptide (CGRP) from sensory nerve terminals of the capsaicin sensitive C-fibers. These pro-inflammatory neuropeptides produce a marked hyperemia in the anterior segment of the eye, accompanied by increased intraocular pressure, breakdown of the blood-aqueous barrier and myosis. To assess the effects of neurogenic inflammation on the retina, specifically on the immunostaining of neurotransmitters and neurotrophins, as well as on the expression of neurotrophin receptors in the retina. RT-PCR was also accomplished in control and stimulated animals to confirm the immunohistochemical results. In the electrically stimulated eyes, immunostaining for SP, CGRP, VIP and nNOS demonstrated a marked increase in the RPE/POS (Retinal Pigment Epithelium/Photoreceptor Outer Segments), in the inner and outer granular layers and in the ganglion cells in comparison to the control eyes. CGRP and SP were found increased in stimulated animals and this result has been confirmed by RT- PCR. Changes in neurotrophin immunostaining and in receptor expression were also observed after electric stimulation of trigeminal ganglia. Decrease of BDNF and NT4 in the outer and inner layers and in ganglion cells was particularly marked. In stimulated rat retinas immunostaining and RT-PCR showed a NGF expression increase. Neurotrophin receptors remained substantially unchanged. These studies demonstrated, for the first time, that antidromic stimulation of the trigeminal ganglion and subsequent neurogenic inflammation affect immunostaining of retinal cell neurotransmitter/neuropeptides and neurotrophins as well as the expression of neurotrophin receptors.
Asunto(s)
Factores de Crecimiento Nervioso/metabolismo , Inflamación Neurogénica/metabolismo , Neurotransmisores/metabolismo , Retina/metabolismo , Animales , Péptido Relacionado con Gen de Calcitonina/genética , Péptido Relacionado con Gen de Calcitonina/metabolismo , Estimulación Eléctrica , Expresión Génica , Masculino , Factores de Crecimiento Nervioso/genética , Inflamación Neurogénica/genética , Inflamación Neurogénica/patología , Neurotransmisores/genética , Células Fotorreceptoras/metabolismo , Epitelio Pigmentado Ocular/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptores de Factor de Crecimiento Nervioso/genética , Receptores de Factor de Crecimiento Nervioso/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sustancia P/genética , Sustancia P/metabolismo , Péptido Intestinal Vasoactivo/metabolismoRESUMEN
Insulin-like growth factors (IGF-I/-II) are not only the endocrine mediators of growth hormone-induced metabolic and anabolic actions but also polypeptides that act in a paracrine and autocrine manner to regulate cell growth, differentiation, apoptosis and transformation. The IGF system is a complex network comprised of two growth factors (IGF-I and -II), cell surface receptors (IGF-IR and -IIR), six specific high affinity binding proteins (IGFBP-I to IGFBP-6), IGFBP proteases as well as several other IGFBP-interacting molecules, which regulate and propagate IGF actions in several tissues. Besides their broad-spectrum physiological and pathophysiological functions, recent evidence suggests even a link between IGFs and different malignancies.
Asunto(s)
Endopeptidasas/fisiología , Proteínas de Unión a Factor de Crecimiento Similar a la Insulina/fisiología , Somatomedinas/fisiología , Envejecimiento/fisiología , Animales , Humanos , Metaloendopeptidasas/fisiología , Proteína Plasmática A Asociada al Embarazo/fisiología , Receptor IGF Tipo 1/fisiología , Receptor IGF Tipo 2/fisiología , Receptor de Insulina/fisiologíaRESUMEN
The aim of this randomized, double-blind, placebo-controlled clinical trial was to determine the efficacy of a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10 (Phototrop) on the visual functions and fundus alterations in early age-related macular degeneration (AMD). One hundred and six patients with a clinical diagnosis of early AMD were randomized to the treated or control groups. The primary efficacy variable was the change in the visual field mean defect (VFMD) from baseline to 12 months of treatment, with secondary efficacy parameters: visual acuity (Snellen chart and ETDRS chart), foveal sensitivity as measured by perimetry, and fundus alterations as evaluated according to the criteria of the International Classification and Grading System for AMD. The mean change in all four parameters of visual functions showed significant improvement in the treated group by the end of the study period. In addition, in the treated group only 1 out of 48 cases (2%) while in the placebo group 9 out of 53 (17%) showed clinically significant (>2.0 dB) worsening in VFMD (p = 0.006, odds ratio: 10.93). Decrease in drusen-covered area of treated eyes was also statistically significant as compared to placebo when either the most affected eyes (p = 0.045) or the less affected eyes (p = 0.017) were considered. These findings strongly suggested that an appropriate combination of compounds which affect mitochondrial lipid metabolism, may improve and subsequently stabilize visual functions, and it may also improve fundus alterations in patients affected by early AMD.
Asunto(s)
Acetilcarnitina/uso terapéutico , Ácidos Grasos Omega-3/uso terapéutico , Fondo de Ojo , Degeneración Macular/tratamiento farmacológico , Ubiquinona/análogos & derivados , Ubiquinona/uso terapéutico , Agudeza Visual/efectos de los fármacos , Adulto , Anciano , Coenzimas , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Resultado del Tratamiento , Pruebas del Campo VisualRESUMEN
Free radicals are involved in several pathological processes in living organisms, for example in athero- and oncogenesis. Some steroids are known to be effective antioxidants, while others do not play any such role. The aim of our study was to examine the antioxidant capability of different metabolites in the synthesis of steroid hormones. As a model, we chose human neutrophils producing superoxide anion, which is the source of many other radicals. Neutrophils were separated from healthy volunteers. Isolated cells were incubated with varying concentrations of steroid compounds and stimulated with N-formyl-Met-Leu-Phe. Superoxide anion production was determined by photometry. Neutrophils incubated with corticosterone and 18-hydroxy-deoxycorticosterone showed a significant reduction in superoxide production, whereas we found a significant enhancement in the presence of 11beta-hydroxyprogesterone. Furthermore, we observed a non-significant decreasing trend after incubation with cholesterol 3-sulphate and an increasing tendency using 11-hydroxyandrostenedione. We were also able to produce newer morphological and functional evidence of the role of myeloperoxidase enzyme in the steroidal antioxidant effect by electronic microscopy and use of sodium hypochlorite in our incubation model. Based on these results, we conclude that not only steroid end products but also their intermediate metabolites, most of which are also present in human plasma, partly influence free radical metabolism. Thus, this study provides further argument for the search for the molecular basis responsible for the antioxidant effect of steroid structures. This may lead to new opportunities for finding really efficient antioxidants, which might perhaps be used in a combined manner with other agents in the fight against certain life-threatening diseases.
Asunto(s)
Desoxicorticosterona/análogos & derivados , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Profármacos/farmacología , Esteroides/farmacología , Superóxidos/metabolismo , Adulto , Anciano , Antioxidantes/farmacología , Ésteres del Colesterol/farmacología , Corticosterona/farmacología , Desoxicorticosterona/farmacología , Femenino , Humanos , Masculino , Microscopía Electrónica , Persona de Mediana Edad , N-Formilmetionina Leucil-Fenilalanina/farmacología , Neutrófilos/enzimología , Neutrófilos/ultraestructura , Peroxidasa/metabolismo , Superóxidos/antagonistas & inhibidoresAsunto(s)
Mapeo Cromosómico , Cromosomas Humanos Par 3/genética , Genes Dominantes/genética , Queratocono/genética , Adulto , Anciano , Colágeno Tipo VIII/genética , Femenino , Haplotipos , Humanos , Italia , Queratocono/patología , Queratocono/fisiopatología , Escala de Lod , Masculino , Persona de Mediana Edad , LinajeRESUMEN
Recent histopathologic studies have shown that mitochondria and peroxisomes of the retinal pigment epithelium may play a central role in the pathophysiology of age-related macular degeneration (AMD). We supposed that compounds which improve mitochondrial functions (mitotropic compounds) may show beneficial effects in preventing AMD. Fourteen patients affected by early AMD were treated with a mixture containing acetyl-L-carnitine (ALC), polyunsaturated fatty acids (PUFAs), coenzyme Q10 (CoQ10) and vitamin E, while an equal number of age- and sex-matched patients affected by early AMD were treated with vitamin E only. Recovery time after macular photostress, foveal sensitivity and mean defect in the visual field as well as blood lipid levels were recorded at the beginning and after 3, 6, 9, 12 and 24 months of follow-up. In the treated group, all the visual functions showed slight improvement which was evident after 3 months of treatment and remained nearly stationary by the end of 24 months. The same tests in the control group showed slow worsening. The divergence between treated and control groups became more marked with time, but the difference was not significant at any time of the follow-up. These findings suggest that the blend of ALC, PUFA, CoQ10 and vitamin E may improve retinal functions in early AMD.
Asunto(s)
Acetilcarnitina/uso terapéutico , Ácidos Grasos Insaturados/uso terapéutico , Degeneración Macular/tratamiento farmacológico , Retina/efectos de los fármacos , Ubiquinona/análogos & derivados , Ubiquinona/uso terapéutico , Vitamina E/uso terapéutico , Anciano , Antioxidantes/uso terapéutico , Coenzimas , Quimioterapia Combinada , Femenino , Humanos , Lípidos/sangre , Degeneración Macular/sangre , Degeneración Macular/fisiopatología , Masculino , Persona de Mediana Edad , Mitocondrias/efectos de los fármacos , Peroxisomas/efectos de los fármacos , Proyectos Piloto , Retina/fisiopatología , Campos Visuales/fisiologíaRESUMEN
In the middle of the 1990s the European Environment Agency (EEA) started to develop a data collecting system for surface and subsurface water resources for assessing pressures, states and impacts on European water resources. The main objective of this system was to provide reliable, comparable, homogenous information, and support integrated environmental assessments at European level. The data collecting system for water is called Eurowaternet. The extent and information content of the network makes not only pan-European, but also regional or thematic environmental assessments possible. An extensive programme started in 1997 to support the Phare countries in their accession to the EU with implementation of this data collecting system in their countries. The paper briefly introduces the methodology of the system, but it focuses more on the application of the system in the accession countries, highlighting, through examples, the usefulness of the implemented network and assembled database. The examples present--among several other possible ones--trends of average nutrient concentrations; relationships between catchment size and annual average nutrient concentrations; relationships between catchment size and agricultural usage.
Asunto(s)
Monitoreo del Ambiente/normas , Ríos , Abastecimiento de Agua/normas , Bases de Datos Factuales , Europa (Continente) , Cooperación Internacional , Control de Calidad , Valores de Referencia , Reproducibilidad de los Resultados , Contaminantes del Agua/análisisRESUMEN
Liver steatosis is a common human disease, most often caused by long-term alcohol consumption. Non-alcoholic steatohepatitis (NASH) is characterized by similar histopathological features to those observed in alcoholic liver disease, but occurs in the absence of significant alcohol consumption. Several aetiological factors contribute to NASH: obesity, type 2 diabetes mellitus, hyperlipidaemia, pregnancy, different chemical intoxications, parenteral nutrition, jejeuno-ileal bypass, chronic inflammatory bowel disease, nutritional protein deficiency and congenital metabolic disorders. Biochemically, oxidative stress and lipid peroxidation and their ensuing damage are implicated in the pathogenesis of NASH and alcoholic steatohepatitis (probably resulting from free fatty acids in the mitochondria, and induction of the cytochrome P450 isoform CYP2E1 in hepatocytes and Kupffer's cells). This paper deals with the pathomechanisms, clinical findings and currently available therapies for NASH. The potential use of metadoxine in the treatment of NASH is also discussed.
Asunto(s)
Hígado Graso/tratamiento farmacológico , Hígado Graso/patología , Piridoxina/uso terapéutico , Ácido Pirrolidona Carboxílico/uso terapéutico , Antioxidantes/uso terapéutico , Combinación de Medicamentos , Hígado Graso/etiología , Femenino , Humanos , Embarazo , Complicaciones del Embarazo/etiología , Complicaciones del Embarazo/metabolismoRESUMEN
Neutrophil granulocytes are involved in the pathogenesis of atherosclerosis also through their free radical generation. The aim of the study was to test how extracellular levels of myeloperoxidase (MPO; a granulocyte enzyme playing role in free radical production) change by age and what effect this change has on the production of the free radical superoxide anion by neutrophils. We also wanted to examine whether the antioxidant effect of different steroid hormones is realized through the MPO. Plasma myeloperoxidase concentrations of healthy blood donors were quantified by ELISA. Superoxide anion production was measured by photometry. Myeloperoxidase concentration was significantly lower in plasmas obtained from older women and men than in those from younger subjects. Adding the MPO inhibitors 4-aminobenzoic acid hydrazide (ABAH) and indomethacin to the granulocytes, the generation of superoxide anion increased and the decreasing effect of the steroids on superoxide production was inhibited. Incubating the neutrophils with the product of the reaction catalyzed by MPO itself (hypochlorite anion), we found significant decrease in superoxide generation. According to our results MPO seems to diminish the production of superoxide anion and so probably has an antioxidant ability. Therefore, its lower plasma levels may contribute to the increasing incidence of atherosclerosis and other free radical mediated disorders in old people. Thus, after further studies MPO might become one of the indicators of cardiovascular risk and the scavenger capacity in general.
Asunto(s)
Peroxidasa/sangre , Posmenopausia/sangre , Premenopausia/sangre , Superóxidos/metabolismo , Adulto , Anciano , Compuestos de Anilina/farmacología , Células Cultivadas , Inhibidores Enzimáticos/farmacología , Femenino , Humanos , Indometacina/farmacología , Masculino , Persona de Mediana Edad , Neutrófilos/citología , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Peroxidasa/antagonistas & inhibidores , Esteroles/farmacología , Testosterona/farmacologíaRESUMEN
PURPOSE: To compare the corneal toxicity of xylazine (XYL)/ketamine (KET) with that of clonidine (CLO)/KET in the rat, in the presence or not of the alpha(2)-adrenergic antagonist yohimbine (YOH). METHODS: XYL (10 mg/kg) and CLO (0.15 mg/kg) were administered subcutaneously in the rat in combination with KET (50 mg/kg), in the presence or not of YOH (2 mg/kg). RESULTS: The corneas immediately lost transparency and luster, but recovered within 120 min. By both light and electron microscopy, a marked stromal edema and alterations of all layers were observed. In addition, XYL/KET altered the permeability of the cornea as indicated by the augmented levels of (14)C-indomethacin, topically administered 30 min after the anesthetic combination. CONCLUSIONS: The mechanism of the corneal toxicity of XYL and CLO in the rat is unclear but we speculate that: (a) proptosis and inhibition of normal blinking did not play a major role because topical application of hyaluronic acid did not protect against it; corneal decompensation, edema and opacification could be due to (b) osmotic or (c) mechanical endothelial stress: the first resulting from the sudden increase of the glucose concentration in the aqueous humor due to the well-known inhibition of insulin release by alpha(2)-adrenergic agonists, and the second from the acute elevation of intraocular pressure caused by these alpha(2)-adrenergic mydriatics in the rat; (d) addition, XYL and CLO could act by directly interacting with local alpha(2)- or, possibly, alpha(1)-adrenergic receptors, whose function is still not clear but probably essential for corneal homeostasis.
Asunto(s)
Anestésicos Combinados/toxicidad , Clonidina/toxicidad , Córnea/efectos de los fármacos , Edema Corneal/inducido químicamente , Ketamina/toxicidad , Xilazina/toxicidad , Agonistas alfa-Adrenérgicos/toxicidad , Antagonistas Adrenérgicos alfa/toxicidad , Anestésicos Disociativos/toxicidad , Animales , Córnea/ultraestructura , Edema Corneal/patología , Opacidad de la Córnea/inducido químicamente , Opacidad de la Córnea/patología , Masculino , Ratas , Ratas Long-Evans , Yohimbina/toxicidadRESUMEN
BACKGROUND: Interleukin 1beta (IL-1beta) and its natural antagonist have been implicated in the pathogenesis of inflammatory bowel disease (IBD). Both cytokines influence bone formation. IL-1beta stimulates osteoclast activity while interleukin 1 receptor antagonist (IL-1ra) enhances bone formation. AIMS: To determine whether the decreased bone mass in IBD is related to gene polymorphisms coding for IL-1beta and IL-1ra, and thus identify patients with an increased risk. METHODS: Bone mineral densitometry was performed at the femoral neck, lumbar spine, and the distal third of the radius in 75 IBD patients (34 men/41 women; 40.3 (1.6) years) and in 58 healthy controls (HC; 28 men/30 women; 32.4 (1.2) years). Values were correlated with the TaqI and AvaI gene polymorphisms in the IL1B and the variable number of tandem repeats gene polymorphism in the IL1RN gene. RESULTS: In IBD patients, but not in HC, carriers of allele 2 at the AvaI gene polymorphism (IL1B-511*2) had significantly lower Z scores at the lumbar spine (-0.82 (0.13) v -0.29 (0.21) p=0.03) and the femoral neck (-0.59 (0.14) v 0.15 (0.19); p=0.003) than non-carriers. These patients also had a higher risk for osteopenia or osteoporosis at the femoral neck (odds ratio 3.63 (95% confidence interval 0.95-13.93)). No association was found between bone mass and the other gene polymorphisms analysed in IBD patients or in HC. CONCLUSIONS: Our results suggest that genetic variability may be a major determinant of bone loss in IBD. Carriers of IL1B-511*2, who are hypersecretors of IL-1beta, have a higher risk of presenting with low bone mass in IBD. Screening for this allele may contribute to determination of the risk of bone loss at the time of disease onset.
Asunto(s)
Densidad Ósea/genética , Variación Genética , Enfermedades Inflamatorias del Intestino/genética , Interleucina-1/genética , Absorciometría de Fotón , Adulto , Alelos , Análisis de Varianza , Densidad Ósea/fisiología , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Osteoporosis/genética , Polimorfismo Genético , Receptores de Interleucina-1/antagonistas & inhibidores , Receptores de Interleucina-1/genética , Secuencias Repetidas en Tándem/genéticaRESUMEN
The tumorous processes, increased level of tumor markers and the change of free radical status are associated in patents with gastrointestinal tumors. The aim of this study was to examine free radical status and tumor markers in patients with gastrointestinal tumors. Two hundered and thirteen patients with gastrointestinal tumor were examined. In the control group 44 non-tumorous patients were examined. The tumor markers (CEA, CA 19-9, CA 72-4, AFP, TPA, AGP) and free radical status (total scavenger capacity) were diagnosed using venal blood (obtained by LIA-kits and chemiluminescent methods, LIA-mAT and the Lumat Berthold instrument). It has been found that: (1) The results showed that the tumor markers, TPA and AGP are the best indicators for the tumorous process; (2) The AGP serum level was in the operable case 91.56+/-38.29 mg/dl meanwhile its value was, 128.46+/-47.62 mg/dl (P<0.001) in the inoperable case; and (3) The TPA value was 118.37+/-155.47 mg/dl in the operable case, (P<0.001) while its value was 227.32+/-244.39 mg/dl in inoperable cases. The significantly high levels of the plasma Chemiluminescent Light Intensity (CLI)=28.12+/-25.96; was obtained in patients with rectal tumors vs. in the control cases CLI= 4.27+/-5.12 RLU% (Relative Light Unit; mean+S.D.; P<0.005). In six of these cases, the free radical status examination indicated the presence of the tumor, even though the level of tumor markers was normal. It has been concluded that the testing of both regular tumor markers and free radical status has an important role in the diagnosis and monitoring of the patients with gastrointestinal tumors.
Asunto(s)
Biomarcadores de Tumor/sangre , Radicales Libres/sangre , Neoplasias Gastrointestinales/sangre , Adulto , Anciano , Femenino , Neoplasias Gastrointestinales/diagnóstico , Humanos , Mediciones Luminiscentes , Masculino , Persona de Mediana Edad , Valores de Referencia , VenasRESUMEN
Our aim was to study the antioxidant and immunomodulatory effect of silibinin and vitamin E on the early postoperative course in rats that had undergone a partial hepatectomy (PHX). Male Wistar rats that were treated with silibinin (50 mg/b.w.kg i.p.) and/or vitamin E (500 mg/b.w.kg p.o.) were randomised to undergo 70% PHX. At 72 h after operation, Concanavalin A (Con-A) induced lymphocyte proliferation, and lipopolysaccharide (LPS) induced interleukin-1 (IL-1) mitogenicity and tumour necrosis factor-alpha (TNF-alpha) cytotoxicity were measured in the spleen. In addition, total free radical scavenger capacity of the liver was analysed. In PHX animals, Con-A induced lymphocyte proliferation was significantly decreased, and both LPS induced IL-1 and TNF-alpha activity were significantly increased as compared to Sham treated animals. Treatment with silibinin and vitamin E synergistically restored both lymphocyte proliferation (P<0.01) and cytokine activity (P<0.001) in PHX animals. In addition, silibinin and vitamin E synergistically (P<0.001) restored total hepatic free radical scavenger capacity as well as serum levels of AST and gammaGT, that were all markedly decreased in PHX animals. Our results suggest that preoperative treatment with silibinin and/or vitamin E modulates the cellular immunoresponse and restores impaired liver function following PHX, presumably through their antioxidant capacity. This may explain their beneficial effects on the postoperative course of liver repair.
Asunto(s)
Antioxidantes/farmacología , Inmunidad Celular/efectos de los fármacos , Hígado/efectos de los fármacos , Silimarina/farmacología , Bazo/efectos de los fármacos , Vitamina E/farmacología , Animales , Radicales Libres/metabolismo , Hepatectomía , Hígado/enzimología , Pruebas de Función Hepática , Masculino , Ratas , Ratas Wistar , Bazo/metabolismoRESUMEN
Malignancies have a distinguished role among leading causes of death around the world. As a result of more effective preventive efforts of cardiovascular diseases malignancies will reach the top of death statistics in the near future. The increased incidence of malignant tumors may be attributed to smoking, in temperate alcohol abuse, as well as inappropriate nutrition. Inappropriate nutrition is thought to be responsible for the development of about 30-50% of malignancies. In the present review the authors analyze the uniform theory of carcinogenesis and the possible mechanisms by which certain nutritive factors may interfere with the complex process of carcinogenesis. The mechanism of "oxidative stress" is detailed, in particular the impact of prooxidants (also referred to as free radicals) on tumor development and the central role of lipid peroxidation. In addition to alimentary free radicals the relevance of alcohol abuse in carcinogenesis is also studied. Against the undesirable free radical reactions a complex natural antioxidant (free radical scavenger) system exists, that is responsible for anticarcinogenesis. The authors introduce the dietary antioxidants, their known effects of mechanisms, and their possible role in chemoprevention and therapy of malignancies, based on several experimental and epidemiological data.
Asunto(s)
Anticarcinógenos/farmacología , Antioxidantes/farmacología , Carcinógenos/efectos adversos , Neoplasias/inducido químicamente , Neoplasias/prevención & control , Fenómenos Fisiológicos de la Nutrición , Oxidantes/efectos adversos , Ácido Ascórbico/farmacología , Flavonoides/farmacología , Humanos , Selenio/farmacología , Superóxido Dismutasa/farmacología , Vitamina A/farmacología , Vitamina E/farmacologíaRESUMEN
Patients with porphyria cutanea tarda (PCT) develop hepatocellular carcinoma as a late consequence. Pre-loading of C57BL/10ScSn mice with iron greatly sensitizes them to the induction of hepatic porphyria caused by hexachlorobenzene (HCB). HCB will also cause liver tumors in experimental animals. Elevated liver iron stores are implicated in the development of some human liver cancers in connection with its known catalytic role in generation of highly reactive activated oxygen species. The aim of this study was to determine the lipid and DNA oxidative damage in iron and HCB-induced porphyric mice. C57BL/10ScSn mice received i.p. injections of dextran sulfate (control), iron (Imferon) or combined iron and HCB. 6 weeks after treatment plasma ALT levels and hepatic free iron, porphyrin, lipid peroxides and 8-hydroxyguanosine (8-OHdG) levels were analyzed. Hepatic porphyrin level was significantly (p < 0.001) increased following combined iron/HCB treatment as compared to control mice. The level of lipid peroxides increased 9-fold (p = 0.001) and 35-fold (p < 0.001) after iron and iron/HCB treatment respectively, whereas the level of 8-OHdG was increased 2.5-fold (p = 0.002) and 7.5-fold (p < 0.001) after iron and iron/HCB treatment respectively as compared to control mice. The authors conclude that iron overload in conjugation with HCB induce lipid and DNA oxidative damage in C57BL/10ScSn mice. DNA oxidative damage may be important in the early events of hepatic carcinogenesis in experimental porphyria.